The purpose of this study was to describe Anaplasma phagocytophilum infection of three cats in Poland showing signs of fever, swollen and painful joints, pale mucous membranes and epistaxis. Morulae consistent with A phagocytophilum were present within the neutrophils of two of the cats. A polymerase chain reaction (PCR) was found targeting the 16S rRNA gene amplified DNA consistent with A phagocytophilum in the blood of all three cats. The sequence of the PCR product obtained showed 99.6-100% homology with the sequence of A phagocytophilum, gene number EU 090186 from Genbank. Applied therapy (including administration of tetracyclines for 3 weeks) resulted in a gradual clinical recovery.
The aim of this study was to assess cardiac disorders in dogs infected with B. canis. The study included 50 dogs with babesiosis and 20 healthy control animals. All the animals had haematological tests, ECG, echocardiography and serum troponin I and CK-MB levels checked. The haematology in the group of dogs with babesiosis confirmed thrombocytopaenia in 100% of dogs, decreased haematocrit in 52% and anaemia in 46%. The most common abnormalities in ECG and echocardiography in dogs infected with protozoa included: change in appearance and/or amplitude of the T-wave (34%), increased fractional shortening (24%), an increased sinus rhythm (14%) and heart axis deviation (10%). In 19 of the 50 dogs with babesiosis, the level of serum troponin I was elevated. In 2 dogs that died from babesiosis, the troponin level I was very high. The ECG confirmed sinus tachycardia and interpolated ventricular beat in these animals. In all dogs with babesiosis that were used in the study, the serum CK-MB was high or very high and was within limits of 23.17 U/L -369.62 U/L. The highest kinase concentration (367.33 U/L and 369.62 U/L) was observed in dogs that died due to the disease. The presented results prove that cardiac changes are common in canine babesiosis, but that most changes are nonspecific and appear to have little clinical significance. Cardiovascular assessment should be based on the assessment of the level of troponin I and CK-MB in the serum of sick animals. High concentrations of these factors might be indicators of poor prognosis.
-Typical European propolis is an antibiotic substance derived from the resin of poplar, birch, and aspen buds. Here, we tested the ability of propolis originating from the resins of these plants to inhibit the in vitro growth of Paenibacillus larvae , the organism that causes American foulbrood, a fatal honeybee larval disease. The study involved GC-MS analysis of extracts from nine samples of propolis gathered from the temperate climate zone of Europe. The extracts showed noticeable differences in the content of flavonoids and other phenolic compounds. Despite the differences in chemical composition, all tested extracts inhibited the growth of P. larvae , with a minimum inhibitory concentration of 7.8 to 62.4 μg mL −1. It was found that not only did the content of flavonoids affect the strength of antimicrobial activity, but other phenolics, such as the phenylpropenoids hydroxycinnamyl sesquiterpenols, glycerides and benzoates also had an effect. This is the first report on the comparative activity of different types of European propolis against P. larvae.Paenibacillus larvae / American foulbrood / Apis mellifera / propolis / antibacterial action
The present study focuses on the antibacterial activity of selected plant extracts against Paenibacillus larvae , the causal agent of American foulbrood disease of honey bees. A gas chromatography-mass spectrometry method was used to analyze six diethyl ether extracts of two white birch species, black poplar and common aspen buds, as well as n-hexane, diethyl ether, and methanol extracts of young twigs from downy and silver birches. Among the identified extract constituents were flavonoids, phenylpropenoids, triterpenoids, and glucosides. In spite of significant differences in qualitative and quantitative composition, all tested in vitro extracts demonstrated high anti-P. larvae activity at minimal inhibitory concentration levels between < 1.0 and 125 μg/mL. To examine the cause of such disparity, the anti-P. larvae activity of some individual constituents naturally present in plant extract compounds was determined. A higher susceptibility of P. larvae (ERIC I) to relatively poorly polar triterpenoid levels compared to polar compounds, flavonoids, and glucosides was demonstrated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.